Creutzfeldt-Jakob disease in Mexico

被引:7
|
作者
Velasquez-Perez, Leora
Rembao-Bojorquez, Daniel
Guevara, Jorge
Guadarrama-Torres, Rosa Maria
Trejo-Contreras, Araceli
机构
[1] Natl Inst Neurol & Neurosurg, Dept Epidemiol, Mexico City 14269, DF, Mexico
[2] Natl Inst Neurol & Neurosurg, Dept Pathol, Mexico City 14269, DF, Mexico
[3] Natl Inst Neurol & Neurosurg, Neurodegenerat Dis Lab, Mexico City 14269, DF, Mexico
关键词
Creutzfeldt-Jakob disease; encephalopathy; epidemiology; prion;
D O I
10.1111/j.1440-1789.2007.00807.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Creutzfeldt-Jakob disease (CJD) is classified within the group of transmissible spongiform encephalopathies (TSE). It is a rapidly progressive illness that affects mental functions. The average age of onset is 50 years. Various tests can help orient the clinical diagnosis, but the confirmatory test is still the post mortem analysis. The aim of this study was to describe the epidemiological, clinical and histopathological characteristics of patients diagnosed as suffering from CJD, at the National Institute of Neurology and Neurosurgery of Mexico (NINN). An observational, descriptive and transversal study was conducted. We collected information concerning these cases from the Departments of Epidemiology and Pathology, as well as the clinical charts of the patients with a diagnosis of CJD. Fifteen cases were registered of which three CJD cases were definite, five probable cases were identified, and seven were possible. The average age of the patients was 49 years. Two definite cases were female and one was male. It is important to improve the systems for surveillance of this type of disease and, furthermore, to permit greater accessibility to laboratories where the procedures necessary for supporting diagnosis can be followed.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 50 条
  • [31] Creutzfeldt-Jakob disease: A protein disease
    Knight, R
    PROTEOMICS, 2001, 1 (06) : 763 - 766
  • [32] Creutzfeldt-Jakob disease: A disease overview
    Cyngiser, Tracy A.
    Neurodiagnostic Journal, 2008, 48 (03) : 199 - 208
  • [33] Epidemiological studies on Creutzfeldt-Jakob disease in Poland
    Kulczycki, J
    Lojkowska, W
    Niedzielska, K
    FOLIA NEUROPATHOLOGICA, 2001, 39 (03) : 175 - 179
  • [34] Incidence rate of Creutzfeldt-Jakob disease in Japan
    Nakamura, Y
    Yanagawa, H
    Hoshi, K
    Yoshino, H
    Urata, J
    Sato, T
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (01) : 130 - 134
  • [35] Neuropathology of the new variant of Creutzfeldt-Jakob disease
    Gonzalo-Pascual, I
    Cuadrado-Corrales, N
    REVISTA DE NEUROLOGIA, 2000, 31 (02) : 160 - 161
  • [36] CREUTZFELDT-JAKOB DISEASE - CLINICAL PICTURE ANALYSIS
    DROBNY, M
    KRAJNAK, V
    SVALEKOVA, A
    PITHOVA, B
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1991, 7 (05) : 511 - 516
  • [37] Tau pathology in Creutzfeldt-Jakob disease revisited
    Kovacs, Gabor G.
    Rahimi, Jasmin
    Stroebel, Thomas
    Lutz, Mirjam I.
    Regelsberger, Guenther
    Streichenberger, Nathalie
    Perret-Liaudet, Armand
    Hoeftberger, Romana
    Liberski, Pawel P.
    Budka, Herbert
    Sikorska, Beata
    BRAIN PATHOLOGY, 2017, 27 (03) : 332 - 344
  • [38] Sporadic Creutzfeldt-Jakob disease: phenotypic variability
    Moreno, MJ
    Romero, J
    NEUROLOGIA, 2002, 17 (07): : 366 - 377
  • [39] Creatine kinase elevation in Creutzfeldt-Jakob disease
    Finsterer, Josef
    Gelpi, Ellen
    GERONTOLOGY, 2006, 52 (04) : 264 - 266
  • [40] The future and problems of vigilance in Creutzfeldt-Jakob disease
    Cuesta, JDP
    REVISTA DE NEUROLOGIA, 2000, 31 (02) : 167 - 170